Uterine development in patients with Turner syndrome: relation to hormone replacement therapy and karyotype
- PMID: 22876536
- DOI: 10.1515/jpem-2012-0040
Uterine development in patients with Turner syndrome: relation to hormone replacement therapy and karyotype
Abstract
Our study aimed to assess uterine development in Turner syndrome patients and its relation to dose and type of estrogen therapy; and karyotype. Pelvic ultrasound was used to assess uterine size and shape, and ovarian volume in 40 Turner syndrome patients. Information on hormone replacement therapy was collected from patients' notes. Among the 40 patients studied, 57.5% started estrogen therapy and 30% were taking progestins. Sixty-five per cent had immature uterus, 17.5% had fully mature uterus and 17.5% had transitional uterus. Uterine volume was associated with age (p < 0.001), height (p = 0.002), weight (p = 0.001), years of estrogen use (p < 0.001), estrogen dose (p = 0.016), current estrogen use ( p =0.001) and Tanner breast stage ( p <0.001). Uterine volume was not affected by the type of estrogen used ( p =0.40) and karyotype ( p =0.40). Patients with Turner syndrome treated with estrogen (of adequate dose and duration) may attain a normal, mature uterine size and configuration, even at a late start of hormone replacement therapy and regardless of karyotype.
Similar articles
-
The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose.Horm Res. 2003;60(4):198-204. doi: 10.1159/000073233. Horm Res. 2003. PMID: 14530609
-
Effect of Dosage of 17ß-Estradiol on Uterine Growth in Turner Syndrome-A Randomized Controlled Clinical Pilot Trial.J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz061. doi: 10.1210/clinem/dgz061. J Clin Endocrinol Metab. 2020. PMID: 31613320 Clinical Trial.
-
Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001.Hum Reprod. 2005 May;20(5):1418-21. doi: 10.1093/humrep/deh764. Epub 2005 Feb 3. Hum Reprod. 2005. PMID: 15695313
-
Hypogonadism and Sex Steroid Replacement Therapy in Girls with Turner Syndrome.J Pediatr Adolesc Gynecol. 2016 Dec;29(6):542-550. doi: 10.1016/j.jpag.2016.03.005. Epub 2016 Mar 25. J Pediatr Adolesc Gynecol. 2016. PMID: 27018757 Review.
-
Sex hormone replacement therapy for individuals with Turner syndrome.Am J Med Genet C Semin Med Genet. 2019 Mar;181(1):13-17. doi: 10.1002/ajmg.c.31685. Epub 2019 Feb 26. Am J Med Genet C Semin Med Genet. 2019. PMID: 30809949 Review.
Cited by
-
The pubertal development mode of Chinese girls with turner syndrome undergoing hormone replacement therapy.BMC Endocr Disord. 2019 Jul 11;19(1):72. doi: 10.1186/s12902-019-0403-2. BMC Endocr Disord. 2019. PMID: 31296213 Free PMC article.
-
Effects of recombinant human growth hormone therapy on carbohydrate, lipid and protein metabolisms of children with Turner syndrome.Pak J Med Sci. 2014 Jul;30(4):731-4. doi: 10.12669/pjms.304.4546. Pak J Med Sci. 2014. PMID: 25097506 Free PMC article.
-
Late-Onset Puberty Induction by Transdermal Estrogen in Turner Syndrome Girls-A Longitudinal Study.Front Endocrinol (Lausanne). 2018 Feb 8;9:23. doi: 10.3389/fendo.2018.00023. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29472893 Free PMC article.
-
A Validated Normative Model for Human Uterine Volume from Birth to Age 40 Years.PLoS One. 2016 Jun 13;11(6):e0157375. doi: 10.1371/journal.pone.0157375. eCollection 2016. PLoS One. 2016. PMID: 27295032 Free PMC article.
-
An Indonesian adolescent with Turner syndrome and β-thalassemia in low-resource setting: A case report and literature review article.Ann Med Surg (Lond). 2022 Nov 6;84:104854. doi: 10.1016/j.amsu.2022.104854. eCollection 2022 Dec. Ann Med Surg (Lond). 2022. PMID: 36582921 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
